# clm_5820D8A235B7

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 2,551,788,000 United States dollar  
valid_from: 2014-09-30  
valid_to: 2014-12-31  
published: 2014-11-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B9965B5284FE  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 2,551,788,000 United States dollar", as of 2014-09-30 (until 2014-12-31). Claim clm_5820D8A235B7, https://asof.is/claim/clm_5820D8A235B7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2014, filed 2014-11-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217614000046/0001532176-14-000046-index.htm (primary, SEC EDGAR 10-Q Q3 FY2014, published 2014-11-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 2,368,842,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_5820D8A235B7](/claim/clm_5820D8A235B7.md) | [clm_509A448302A2](/claim/clm_509A448302A2.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.